Telemus Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $773K | Buy |
1,899
+8
| +0.4% | +$3.26K | 0.06% | 185 |
|
|
2023
Q3 | $658K | Sell |
1,891
-5
| -0.3% | -$1.74K | 0.06% | 191 |
|
|
2023
Q2 | $667K | Buy |
1,896
+36
| +2% | +$12.7K | 0.06% | 199 |
|
|
2023
Q1 | $586K | Sell |
1,860
-90
| -5% | -$28.4K | 0.05% | 207 |
|
|
2022
Q4 | $566K | Buy |
1,950
+665
| +52% | +$193K | 0.05% | 215 |
|
|
2022
Q3 | $372K | Sell |
1,285
-123
| -9% | -$35.6K | 0.04% | 234 |
|
|
2022
Q2 | $397K | Sell |
1,408
-58
| -4% | -$16.4K | 0.04% | 253 |
|
|
2022
Q1 | $383K | Buy |
1,466
+462
| +46% | +$121K | 0.03% | 252 |
|
|
2021
Q4 | $220K | Buy |
+1,004
| New | +$220K | 0.02% | 345 |
|
|
2020
Q4 | – | Sell |
-3,395
| Closed | -$740K | – | 442 |
|
|
2020
Q3 | $740K | Buy |
3,395
+68
| +2% | +$14.8K | 0.05% | 240 |
|
|
2020
Q2 | $980K | Buy |
3,327
+63
| +2% | +$18.6K | 0.08% | 183 |
|
|
2020
Q1 | $940K | Buy |
+3,264
| New | +$940K | 0.08% | 179 |
|
|
2018
Q1 | – | Sell |
-50
| Closed | -$7K | – | 559 |
|
|
2017
Q4 | $7K | Buy |
+50
| New | +$7K | ﹤0.01% | 540 |
|